المؤلفون: VanBuskirk, Kelley M., O'Neill, Matthew T., De La Vega, Patricia, Maier, Alexander G., Krzych, Urszula, Williams, Jack, Dowler, Megan G., Sacci,, John B., Kangwanrangsan, Niwat, Tsuboi, Takafumi, Kneteman, Norman M., Heppner,, Donald G., Murdock, Brant A., Mikolajczak, Sebastian A., Aly, Ahmed S. I., Cowman, Alan F., Kappe, Stefan H. I., James, Anthony A.

المصدر: Proceedings of the National Academy of Sciences of the United States of America, 2009 Aug 01. 106(31), 13004-13009.

الوصول الحر: https://www.jstor.org/stable/40484640Test

المؤلفون: VanBuskirk, Kelley., O'Neill, Matthew., De la Vega, Patricia., Maier, Alexander., Krzych, Urzsula., Williams, Jack., Dowler, Megan., Sacci Jr., John., Kangwanrangsan, Niwat., Takafumi, Tsuboi., Kneteman, Norman., Heppner, Donald., Murdock, Brant., Mikolajczak, Sebastian., Aly, Ahmed., Cowman, Alan., Kappe, Stefan.

المساهمون: La Trobe University.

المصدر: National Academy of Sciences. Proceedings, 106(31): 13004-13009

مصطلحات موضوعية: 0605 (four-digit-FOR)

العلاقة: http://arrow.latrobe.edu.au:8080/vital/access/HandleResolver/1959.9/165895Test

الإتاحة: http://arrow.latrobe.edu.au:8080/vital/access/HandleResolver/1959.9/165895Test

المؤلفون: De la Vega, Patricia, Kappe, Stefan H. I., O'Neill, Matthew T., Maier, Alexander G., Cowman, Alan F., Mikolajczak, Sebastian A., Murdock, Brant A., Heppner, Donald G., Kneteman, Norman M., Tsuboi, Takafumi, Kangwanrangsan, Niwat, Sacci, John B., Dowler, Megan G., Williams, Jack, Krzych, Urszula, Aly, Ahmed Sayed Ibrahım, VanBuskirk, Kelley M.

مصطلحات موضوعية: VanBuskirk K. M., O-Neill M. T., De la Vega P., Maier A. G., Krzych U., Williams J., Dowler M. G., Sacci J. B., Kangwanrangsan N., Tsuboi T., et al., Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design-, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, cilt.106, ss.13004-13009

الوقت: 2009

الوصف: Falciparum malaria is initiated when Anopheles mosquitoes transmit the Plasmodium sporozoite stage during a blood meal. Irradiated sporozoites confer sterile protection against subsequent malaria infection in animal models and humans. This level of protection is unmatched by current recombinant malaria vaccines. However, the live-attenuated vaccine approach faces formidable obstacles, including development of accurate, reproducible attenuation techniques. We tested whether Plasmodium falciparum could be attenuated at the early liver stage by genetic engineering. The P. falciparum genetically attenuated parasites (GAPs) harbor individual deletions or simultaneous deletions of the sporozoite-expressed genes P52 and P36. Gene deletions were done by double-cross-over recombination to avoid genetic reversion of the knockout parasites. The gene deletions did not affect parasite replication throughout the erythrocytic cycle, gametocyte production, mosquito infections, and sporozoite production rates. However, the deletions caused parasite developmental arrest during hepatocyte infection. The double-gene deletion line exhibited a more severe intrahepatocytic growth defect compared with the single-gene deletion lines, and it did not persist. This defect was assessed in an in vitro liver-stage growth assay and in a chimeric mouse model harboring human hepatocytes. The strong phenotype of the double knockout GAP justifies its human testing as a whole-organism vaccine candidate using the established sporozoite challenge model. GAPs might provide a safe and reproducible platform to develop an efficacious whole-cell malaria vaccine that prevents infection at the preerythrocytic stage.

العلاقة: http://hdl.handle.net/20.500.12645/23306Test; WOS:000268667600079; 69149109035

الإتاحة: https://doi.org/20.500.12645/23306Test
https://doi.org/10.1073/pnas.0906387106Test
https://hdl.handle.net/20.500.12645/23306Test

المؤلفون: VanBuskirk, Kelley M., O'Neill, Matthew T., De La Vega, Patricia, Maier, Alex, Krzych, Urszula, Williams, Jack, Dowler, Megan G., Sacci, John B., Kangwanrangsan, Niwat, Tsuboi, Takafumi, Knetem an, Norman M., Heppner, Donald G., Murdock, Brant A., Mikolajczak, Sebastian A., Aly, Ahmed S.I., Cowman, Alan F., Kappe, Stefan H.I.

المصدر: PNAS - Proceedings of the National Academy of Sciences of the United States of America

مصطلحات موضوعية: Keywords: live vaccine, malaria vaccine, plasmodium falciparum vaccine, protein p 36, protein p52, protozoal protein, unclassified drug, live vaccine, animal experiment, animal model, animal tissue, Anopheles stephensi, article, Genetically attenuated parasites, P36, P52, Sporozoite

الوصف: Falciparum malaria is initiated when Anopheles mosquitoes transmit the Plasmodium sporozoite stage during a blood meal. Irradiated sporozoites confer sterile protection against subsequent malaria infection in animal models and humans. This level of protection is unmatched by current recombinant malaria vaccines. However, the live-attenuated vaccine approach faces formidable obstacles, including development of accurate, reproducible attenuation techniques. We tested whether Plasmodium falciparum could be attenuated at the early liver stage by genetic engineering. The P. falciparum genetically attenuated parasites (GAPs) harbor individual deletions or simultaneous deletions of the sporozoite-expressed genes P52 and P36. Gene deletions were done by double-cross-over recombination to avoid genetic reversion of the knockout parasites. The gene deletions did not affect parasite replication throughout the erythrocytic cycle, gametocyte production, mosquito infections, and sporozoite production rates. However, the deletions caused parasite developmental arrest during hepatocyte infection. The double-gene deletion line exhibited a more severe intrahepatocytic growth defect compared with the single-gene deletion lines, and it did not persist. This defect was assessed in an in vitro liver-stage growth assay and in a chimeric mouse model harboring human hepatocytes. The strong phenotype of the double knockout GAP justifies its human testing as a whole-organism vaccine candidate using the established sporozoite challenge model. GAPs might provide a safe and reproducible platform to develop an efficacious whole-cell malaria vaccine that prevents infection at the preerythrocytic stage.

العلاقة: http://hdl.handle.net/1885/80100Test; https://openresearch-repository.anu.edu.au/bitstream/1885/80100/5/Preerythrocytic.pdf.jpgTest; https://openresearch-repository.anu.edu.au/bitstream/1885/80100/7/01_VanBuskirk_Preerythrocytic,_2009.pdf.jpgTest

الإتاحة: https://doi.org/10.1073/pnas.0906387106Test
http://hdl.handle.net/1885/80100Test
https://openresearch-repository.anu.edu.au/bitstream/1885/80100/5/Preerythrocytic.pdf.jpgTest
https://openresearch-repository.anu.edu.au/bitstream/1885/80100/7/01_VanBuskirk_Preerythrocytic,_2009.pdf.jpgTest